The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2022 | Optimizing transfusion support for patients with MDS
Shuh Ying Tan, MBBS, BMedSci, FRACP, FRCPA, St Vincent’s Hospital Melbourne, Melbourne, Australia, comments on how transfusion support can be optimized for patients with myelodysplastic syndromes (MDS) and factors that should be considered, including the degree of anemia, age of the patient, and comorbidities. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
